Your browser doesn't support javascript.
loading
Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study.
Asonuma, Kunio; Ozeki, Keiji; Yamazaki, Hajime; Okabayashi, Shinji; Okano, Soh; Ozaki, Ryo; Nishimata, Nobuaki; Kiyohara, Hiroki; Ichinari, Naoki; Kobayashi, Taku; Yamada, Masahiro; Matsubayashi, Mao; Yokoyama, Yoko; Arimitsu, Shoko; Umeno, Junji; Munetomo, Yoshinori; Andoh, Akira; Shinzaki, Shinichiro.
  • Asonuma K; Department of Gastroenterology and Hepatology, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Ozeki K; Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Yamazaki H; Section of Clinical Epidemiology, Department of Community Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Okabayashi S; Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Okano S; Center for Inflammatory Bowel Disease, Tokyo Yamate Medical Center, Japan Community Healthcare Organization, Tokyo, Japan.
  • Ozaki R; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Nishimata N; Department of Gastroenterology, Sameshima Hospital, Kagoshima, Japan.
  • Kiyohara H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Ichinari N; Department of Gastroenterology and Hepatology, Center for Digestive Disease and Division of Endoscopy, University of Miyazaki Hospital, Miyazaki, Japan.
  • Kobayashi T; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
  • Yamada M; Department of Gastroenterology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Matsubayashi M; Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Yokoyama Y; Department of Gastroenterology, Faculty of Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Arimitsu S; Kinshukai Infusion Clinic, Osaka, Japan.
  • Umeno J; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Munetomo Y; Department of Gastroenterology, Himeji Central Hospital, Himeji, Japan.
  • Andoh A; Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.
  • Shinzaki S; Department of Gastroenterology, Faculty of Medicine, Hyogo Medical University, Nishinomiya, Japan.
J Gastroenterol Hepatol ; 39(1): 66-73, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37823425
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article